diagnosis of endolymphatic hydrops in hydrocephalus patients
Diagnostic Testthe hydrocephalus could be associated with endolymphatic hydrops, this study designed to show the relationship between both of these diseases by special tests for diagnosis
NCT Number: NCT07003152
The goal of this observational study is to assess the prevalence of endolymphatic hydrops in patients with hydrocephalus and assess the auditory functions in patients with hydrocephalus including male and female with 20-60 year age groups. it aims to assess the prevalence of endolymphatic hydrops in patients with hydrocephalus and to assess the auditory functions in patients with hydrocephalus
Trial opening soon.
Get Notified20 year–60 year
All sexes
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients will be diagnosed with hydrocephalus through the neurosurgery department of the same hospital,
Exclusion criteria
Exclusion criteria
-
the hydrocephalus could be associated with endolymphatic hydrops, this study designed to show the relationship between both of these diseases by special tests for diagnosis
Time frame: 16 weeks
pure-tone audiometry (air conduction and bone conduction) will be done in a clinical soud-isolatedaudiometry room using two-channel diagnostic audiometer model otopront (90 D-65329 Hohenstein, Germany)
Sohag University
Other
Prevalence of Endolymphatic Hydrops Among Patients With Hydrocephalus
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07694518
Brain Diseases, Central Nervous System Diseases
Sohag, Egypt
View Trial DetailsNCT07679035
Brain Diseases, Central Nervous System Diseases
Chicago, Illinois, United States
View Trial DetailsNCT07630051
Brain Diseases, Cardiovascular Diseases
Angers, France
View Trial DetailsNCT07600463
Brain Diseases, Central Nervous System Diseases
Kuopio, Puijonlaaksontie 2, Finland
View Trial Details